# MRG003 With Gemcitabine for Second-line Advanced PDAC

> clinical trial · VERIFIED · 2026-07-06

Status: NOT_YET_RECRUITING · Sponsor: Peking Union Medical College Hospital · Condition: Pancreatic Ductal Adenocarcinoma (PDAC)

- Company: Peking Union Medical College Hospital
- Sector: Pancreatic Ductal Adenocarcinoma (PDAC)
- Primary source: https://clinicaltrials.gov/study/NCT07685470

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.